Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 256
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pα+ Psychedelic Bulletin #225: Q1 Lobbying Update; Individual vs. Group MDMA Therapy Study Launches; Australia Loosens Psychedelics Access Regulations; VA Launches “New” MDMA Trial
Three Brain Injuries, One Iboga Protocol, and What It Tells Us
The War on Drugs Was Never About Drugs. Psychedelic Healing Must Reckon With That.
A Dispatch from APA’s Annual Meeting: Psychedelics Return at an Awkward Moment for American Psychiatry
Momentum Amidst Tumult: The FDA Reshuffle, Approval Timelines, and the Compass-Usona Race
Entheon Biomedical Subsidiary, HaluGen Life Sciences, Announces Agreement with Third Wave
Red Light Holland to Partner with Leading Fresh and Dried Mushroom...
PT249 – Hadas Alterman, Serena Wu, and Adriana Kertzer of Plant...
Filament Announces Shareholder Approval of Amalgamation and Closing of Private Placement...
Psychedelics and Perception Part 1: The First Era of Research
Red Light Holland Provides Initial FAQ in connection with Transaction with...
Psychedelic Bulletin: atai IPOs on Nasdaq; Cybin to Target Anxiety Indications;...
Numinus Wellness Graduates to Tier 1 on the TSX Venture Exchange
PTSF64 – The First Woman to Take Acid, The Drug Policy...
atai Life Sciences Announces Pricing of Upsized Initial Public Offering
Load more